维拉帕米：肥厚型心肌病患者猝死的一个原因。

Perrot B, Danchin N, Terrier de la Chaise A

Br Heart J. 1984 Mar;51(3):352-4. doi: 10.1136/hrt.51.3.352.

Sudden death was recorded by continuous ambulatory electrocardiographic (Holter) monitoring in a 62 year old man with hypertrophic cardiomyopathy and atrial fibrillation, who had been treated for four days with verapamil 360 mg orally. Analysis of the tape showed a third degree atrioventricular block followed by complete asystole. The sudden death could be related to treatment with verapamil.

一名62岁患有肥厚型心肌病和心房颤动的男性，口服维拉帕米360毫克治疗四天后，通过动态心电图（Holter）监测记录到猝死。磁带分析显示三度房室传导阻滞，随后是完全心脏停搏。猝死可能与维拉帕米治疗有关。